RaNA Therapeutics Acquires Shire's Leading mRNA Therapy Platform.

News   Jan 05, 2017 | Original Story From RaNA Therapeutics

 
RaNA Therapeutics Acquires Shire's Leading mRNA Therapy Platform.
 
 
 
 

RELATED ARTICLES

Stem Cells From Young Hearts Could Rejuvenate Old Hearts

News

Cardiac stem cell infusions could someday help reverse the aging process in the human heart, making older ones behave younger, according to a new study from the Cedars-Sinai Heart Institute.

READ MORE

Blood-vessel-on-a-Chip Models Vascular Barrier Function

News

A newly developed human blood-vessel-on-a-chip models the vascular barrier and reveals a new cell migration-based mechanism for fibrotic diseases.

READ MORE

Major Cause of Drug-resistance in Prostate Cancer Patients Identified

News

A recent Nature Medicine paper outlines the role of mutations within the SPOP gene on the development of resistance to one class of drugs.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE